Linnaeus Therapeutics
Organisation
Trials
Phase 2/3, Recruiting, 135 people, 3 Oct 2024
Grants and prizes
Advanced Research Projects Agency for Health
PROSPR, PROSPR: a once-daily compound with an established safety profile and cardiometabolic benefits, tested for aging outcomes, 24 Feb 2026
Sources: arpa-h.gov